Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 80185 Gel vs Dovobet Ointment in Japanese Psoriasis Patients
NCT02668692Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of AKP01 and betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV) (2 arms), sponsored by LEO Pharma. Primary endpoint: Number of Subjects With 'Overall Improvement' for the Target Lesion on the Scalp at 4 weeks. Started Feb 2016; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02668692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668692.